Bedside testing of CYP2C19 gene for treatment of patients with PCI with antiplatelet therapy-Reference-Cited by-同舟云学术

Bedside testing of CYP2C19 gene for treatment of patients with PCI with antiplatelet therapy

Published:2020-06-03 Issue:1 Volume:20 Page:
ISSN:1471-2261
Container-title:BMC Cardiovascular Disorders
language:en
Short-container-title:BMC Cardiovasc Disord

Author:

Al-Rubaish Abdullah M.,Al-Muhanna Fahad A.,Alshehri Abdullah M.,Al-Mansori Mohammed A.,Alali Rudaynah A.,Khalil Rania M.,Al Faraidy Khalid A.,Cyrus Cyril,Sulieman Mohammed M.,Vatte Chittibabu,Claassens Daniel M. F.,ten Berg Jurriën M.,Asselbergs Folkert W.,Al-Ali Amein K.^ORCID

Funder

King Abdulaziz City for Science and Technology

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12872-020-01558-2.pdf

Reference24 articles.

1. Breet NJ, van Werkum JW, Bouman HJ, Kelder JC, Ruven HJ, Bal ET, et al. Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. JAMA. 2010;303(8):754–62. https://doi.org/10.1001/jama.2010.181 .

2. Collet JP, Hulot JS, Pena A, Villard E, Esteve JB, Silvain J, et al. Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study. Lancet. 2009;373(9660):309–17. https://doi.org/10.1016/S0140-6736(08)61845-0 Epub 2008 Dec 26.

3. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115(17):2344–51. https://doi.org/10.1161/CIRCULATIONAHA.106.685313 .